BLND vs NVDA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant operational and profitability concerns. Despite a strong gross margin of 57.53% and a healthy current ratio of 2.54, the company continues to report negative earnings, shrinking revenue, and negative returns across ROE, ROA, and ROIC. Insider selling activity totaling $0.65M over the past six months further signals lack of confidence from management, while the stock trades at a high forward P/E of 26.67 despite unproven earnings sustainability. Although recent quarterly EPS surprises have been volatile and some show improvement, the long-term trend remains weak with a 5-year price decline of 86.6%.
NVDA shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Key strengths include strong valuation and growth metrics. Price trades at a 20.7% premium to fair value estimate ($144.55), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BLND vs NVDA: Head-to-Head Comparison
This page compares Blend Labs, Inc. (BLND) and NVIDIA Corporation (NVDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.